Decoy Therapeutics Inc. (DCOY) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading DCOY…

Decoy Therapeutics Inc. (DCOY) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Decoy Therapeutics Inc.

DCOY · CIK 1615219

4 · Sep 2, 2026 · Chief Business Officer Marschel Peter Klaus was granted 3,900 shares

4

Chief Business Officer Marschel Peter Klaus was granted 3,900 shares

Filed: Sep 2, 2026
Period: Aug 31, 2026
Accession: 0002079859-26-000002
Filer: Decoy Therapeutics Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov